Filing Details
- Accession Number:
- 0000899243-22-033880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-20 16:11:40
- Reporting Period:
- 2022-10-18
- Accepted Time:
- 2022-10-20 16:11:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-10-18 | 1,503 | $300.02 | 39,480 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-10-18 | 288 | $301.84 | 39,192 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
- Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $300.02 (range $300.00 to $300.14).
- Open market sales reported on this line occurred at a weighted average price of $301.84 (range $301.14 to $301.98).
Billionaire Hedge Funds
